Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 49

1.

Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.

Gaubert A, Kauss T, Marchivie M, Ba BB, Lembege M, Fawaz F, Boiron JM, Lafarge X, Lindegardh N, Fabre JL, White NJ, Olliaro PL, Millet P, Grislain L, Gaudin K.

Int J Pharm. 2014 Jul 1;468(1-2):55-63. doi: 10.1016/j.ijpharm.2014.04.023. Epub 2014 Apr 13.

PMID:
24726300
[PubMed - in process]
Free PMC Article
2.

Pharmaceutical development and optimization of azithromycin suppository for paediatric use.

Kauss T, Gaubert A, Boyer C, Ba BB, Manse M, Massip S, Léger JM, Fawaz F, Lembege M, Boiron JM, Lafarge X, Lindegardh N, White NJ, Olliaro P, Millet P, Gaudin K.

Int J Pharm. 2013 Jan 30;441(1-2):218-26. doi: 10.1016/j.ijpharm.2012.11.040. Epub 2012 Dec 3.

PMID:
23220079
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment.

Kauss T, Gaudin K, Gaubert A, Ba B, Tagliaferri S, Fawaz F, Fabre JL, Boiron JM, Lafarge X, White NJ, Olliaro PL, Millet P.

Int J Pharm. 2012 Oct 15;436(1-2):624-30. doi: 10.1016/j.ijpharm.2012.07.030. Epub 2012 Jul 30.

PMID:
22868232
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership.

Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro PL, Millet P.

Malar J. 2011 May 23;10:142. doi: 10.1186/1475-2875-10-142.

PMID:
21605361
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Allogeneic somatic cell therapy: process development challenges and future opportunities.

Fawaz FS, Hermiston TW, Dinter H.

Curr Opin Mol Ther. 2010 Aug;12(4):383-5. Review.

PMID:
20707031
[PubMed - indexed for MEDLINE]
6.

Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria.

Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P.

Int J Pharm. 2010 Jun 1. [Epub ahead of print]

PMID:
20685236
[PubMed - as supplied by publisher]
7.

Fixed artesunate-amodiaquine combined pre-formulation study for the treatment of malaria.

Kauss T, Fawaz F, Guyot M, Lagueny AM, Dos Santos I, Bonini F, Olliaro P, Caminiti A, Millet P.

Int J Pharm. 2010 Aug 16;395(1-2):198-204.

PMID:
20635516
[PubMed - indexed for MEDLINE]
8.

Investigation of porous graphitic carbon at high-temperature liquid chromatography with evaporative light scattering detection for the analysis of the drug combination artesunate--azithromycin for the treatment of severe malaria.

Gaudin K, Millet P, Fawaz F, Olliaro P, White NJ, Cassus-Coussère C, Agbahoungha U, Dubost JP.

J Chromatogr A. 2010 Jan 1;1217(1):75-81. doi: 10.1016/j.chroma.2009.11.015. Epub 2009 Nov 10.

PMID:
19931089
[PubMed - indexed for MEDLINE]
9.

Determination of artesunate using reversed-phase HPLC at increased temperature and ELSD detection.

Gaudin K, Kauss T, Lagueny AM, Millet P, Fawaz F, Dubost JP.

J Sep Sci. 2009 Jan;32(2):231-7. doi: 10.1002/jssc.200800437.

PMID:
19101943
[PubMed - indexed for MEDLINE]
10.

Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis.

Kauss T, Moynet D, Rambert J, Al-Kharrat A, Brajot S, Thiolat D, Ennemany R, Fawaz F, Mossalayi MD.

Arthritis Res Ther. 2008;10(1):R19. doi: 10.1186/ar2372. Epub 2008 Feb 6.

PMID:
18252009
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

In vitro release and stability of an artesunate rectal gel suitable for pediatric use.

Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AM, Dubost JP, Millet P, Fawaz F.

Int J Pharm. 2008 Apr 2;353(1-2):1-7. Epub 2007 Nov 9.

PMID:
18082982
[PubMed - indexed for MEDLINE]
12.

Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpet.

Canal-Raffin M, L'azou B, Martinez B, Sellier E, Fawaz F, Robinson P, Ohayon-Courtès C, Baldi I, Cambar J, Molimard M, Moore N, Brochard P.

Part Fibre Toxicol. 2007 Sep 20;4:8.

PMID:
17883864
[PubMed]
Free PMC Article
13.

From ICU nurse to "miracle" patient.

Fawaz F.

RN. 2007 Aug;70(8):56. No abstract available.

PMID:
17760300
[PubMed - indexed for MEDLINE]
14.

Development of parallel line analysis criteria for recombinant adenovirus potency assay and definition of a unit of potency.

Ogawa Y, Fawaz F, Reyes C, Lai J, Pungor E Jr.

PDA J Pharm Sci Technol. 2007 May-Jun;61(3):183-93.

PMID:
17722485
[PubMed - indexed for MEDLINE]
15.

Stability of artesunate in pharmaceutical solvents.

Gaudin K, Langlois MH, Barbaud A, Boyer C, Millet P, Fawaz F, Dubost JP.

J Pharm Biomed Anal. 2007 Feb 19;43(3):1019-24. Epub 2006 Nov 3.

PMID:
17084575
[PubMed - indexed for MEDLINE]
16.

Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs.

Zheng X, Baker H, Hancock WS, Fawaz F, McCaman M, Pungor E Jr.

Biotechnol Prog. 2006 Sep-Oct;22(5):1294-300.

PMID:
17022666
[PubMed - indexed for MEDLINE]
17.

Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators.

Mamani-Matsuda M, Kauss T, Al-Kharrat A, Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D, Mossalayi MD.

Biochem Pharmacol. 2006 Nov 15;72(10):1304-10. Epub 2006 Sep 7.

PMID:
16959220
[PubMed - indexed for MEDLINE]
18.

A potency assay for a replication incompetent adenovirus type 5 carrying a human fgf-4 gene.

Fawaz FS, Elsheikh MA, Ogawa Y, Files JG, McCaman MT, Pungor E Jr.

Anal Biochem. 2005 Jul 1;342(1):34-44.

PMID:
15958178
[PubMed - indexed for MEDLINE]
19.

Comparative in vitro-in vivo study of two quinine rectal gel formulations.

Fawaz F, Koffi A, Guyot M, Millet P.

Int J Pharm. 2004 Aug 6;280(1-2):151-62.

PMID:
15265555
[PubMed - indexed for MEDLINE]
20.

Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.

Murakami P, Havenga M, Fawaz F, Vogels R, Marzio G, Pungor E, Files J, Do L, Goudsmit J, McCaman M.

J Virol. 2004 Jun;78(12):6200-8.

PMID:
15163713
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk